Adverse events or intercurrent illness throughout treatment with weekly pegIFN-α-2a (135 µg) plus oral Ribavirin (400 mg twice daily); n = 58 patients.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Adverse_events_or_intercurrent_illness_throughout_treatment_with_weekly_pegIFN_945_2a_135_181_g_plus_oral_Ribavirin_400_mg_twice_daily_n_8202_8202_58_patients_/366984
下载链接
链接失效反馈官方服务：
资源简介：
Adverse events or intercurrent illness throughout treatment with weekly pegIFN-α-2a (135 µg) plus oral Ribavirin (400 mg twice daily); n = 58 patients.
创建时间：
2015-12-02
